Nitinote Surgical

Ramat Gan, Israel Founded: 2014 • Age: 12 yrs
Non-surgical bariatric solutions for obesity are developed.

About Nitinote Surgical

Nitinote Surgical is a company based in Ramat Gan (Israel) founded in 2014 by Tamir Wolf. Nitinote Surgical has raised $26.1 million across 3 funding rounds from investors including Elron Ventures, MTIP and Accelmed. Nitinote Surgical offers products and services including EndoZipâ„¢. Nitinote Surgical operates in a competitive market with competitors including Standard Bariatrics, Zeltiq, CoolSculpting, Modius Health and Liposonix, among others.

Key Metrics
  • Total Equity Funding
    $26.1M (USD)

    in 3 rounds

  • Latest Funding Round
    $9.3M (USD), Series B

    Dec 2024

  • Investors

Products & Services of Nitinote Surgical

Nitinote Surgical offers a comprehensive portfolio of products and services, including EndoZip™.

EndoZip™
Endoscopic Suturing System

Automated device for safe gastroplasty in obesity treatment.

Funding Insights of Nitinote Surgical

Nitinote Surgical has successfully raised a total of $26.1M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $9.3 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $26.1M
  • Total Rounds 3
  • Last Round Series B — $9.3M
  • First Round $6.7M

    (Mar 2018)

  • Investors Count 4

All 3 funding rounds of Nitinote Surgical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2024$9.3MSeries B–MTIP
Sep 2023$10.1MSeries B––
Mar 2018$6.7MSeries A–Accelmed
Valuation history

4 investors in total: 4 institutional.

Investors in Nitinote Surgical

Nitinote Surgical has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Elron Ventures, MTIP and Accelmed.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital fund focused on digital health and digital medical device companies
–mtip.chBasel, Switzerland
-
–accelmed.com-
Venture capital firm focused on early-stage technologies companies
1962elronventures.comTel Aviv, Israel
-
–techwald.com-
Premium access

Investor details for Nitinote Surgical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Nitinote Surgical

7 people are tracked at Nitinote Surgical (4 in leadership, 3 in team).

NameRoleGroup
Tamir Wolf
Co-FounderLeadership
Tal Yered
Head Of Research And DevelopmentLeadership
Ravit Peled
Director Of Clinical & Regulatory AffairsLeadership
Raz Bar-On
CTO & Chief Global SupportLeadership
Sheffy Harel
R&d Project ManagerTeam
Marina Dror
EngineerTeam
Benny Gordon
Sinior Development EngineerTeam
Premium access

Complete people profiles for Nitinote Surgical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Nitinote Surgical

3 dated milestones of Nitinote Surgical across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nitinote Surgical is founded.
  2. Funding First funding round of $6.7M.
  3. Funding Latest funding round, Series B, of $9.3M.

Competitors of Nitinote Surgical

Nitinote Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Standard Bariatrics, Zeltiq, CoolSculpting, Modius Health and Liposonix, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
standardbariatrics.com2014Cincinnati, United States$35.5M34
Medical devices for obesity surgical treatment are provided.
zeltiq.com2005Pleasanton, United States$70.42M–
Controlled cooling technology is developed for non-surgical fat reduction.
coolsculpting.com2005Pleasanton, United States–82
Non-surgical fat reduction is achieved through controlled-cooling technology.
modiushealth.com2017Belfast, United Kingdom$1.59M21
Non-invasive vestibular stimulation device for weight loss is offered.
liposonix.com1999Hayward, United States$37.94M6,139
Non-surgical and non-invasive treatment to eliminate unwanted fat around waistline
ultrashape.com2002Irvine, United States$15M–
Non-invasive fat cell destruction for body contouring
hourglasstech.com2007Redwood, United States––
Weight-loss solutions are developed via incision-free transoral procedures.
cabochoninc.com2005Menlo Park, United States$14.79M–
Delivers an ultrasound system for disrupting subcutaneous tissue in medical applications.
elememedical.com2007Merrimack, United States––
Non-invasive laser and light therapy for cellulite reduction is provided.
Premium access

Detailed competitors of Nitinote Surgical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Nitinote Surgical

Premium access

Complete news archive for Nitinote Surgical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Nitinote Surgical

10 companies that operate in the same segment as Nitinote Surgical (Metabolic Diseases), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
2009Wellesley, Massachusetts, United StatesUSD 174.04 MUSD 32.11 M137
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
2010Boston, Massachusetts, United StatesUSD 84 MUSD 189.76 M283
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Developer of cortisol modulators for the treatment of various diseases
1998Menlo Park, California, United States–USD 761.41 M500
Developer of therapies for the treatment of endocrine-related diseases and cancers
2008San Diego, California, United StatesUSD 103.5 MUSD 1.04 M437
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
2009Cambridge, Massachusetts, United StatesUSD 685 M–81
Developer of small molecule therapeutics for endocrine and CNS disorders
1992San Diego, California, United StatesUSD 10 MUSD 2.86 B1,800
Solutions for biomarker discovery and diagnostic testing are provided.
2000Morrisville, United StatesUSD 165.87 M––
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
2007Fremont, California, United StatesUSD 61.1 MUSD 407.32 M395
Biologics are developed for cardio-metabolic and liver diseases.
2007San Francisco, California, United StatesUSD 358.87 MUSD 330.53 M–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nitinote Surgical

Nitinote Surgical was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Nitinote Surgical is headquartered in Ramat Gan, Israel. It is registered at Ramat Gan, Tel Aviv District, Israel.

Nitinote Surgical is a funded company, having raised a total of $26.1M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6.7M, raised on Mar 2018.

Nitinote Surgical was founded in 2014 in Ramat Gan, Israel, within the medical device sector. Non-surgical bariatric solutions addressing obesity are being developed by the company. Funding was secured from Accelmed, an investment firm specializing in medical technologies. Operations are conducted from Peregrines incubator as of April 2017, with product details remaining undisclosed. Tamir Wolf serves as co-founder.

Nitinote Surgical's top competitors include CoolSculpting, Standard Bariatrics and Liposonix.

Nitinote Surgical offers EndoZipâ„¢.

Nitinote Surgical has 4 investors. Key investors include Elron Ventures, MTIP, Accelmed, and TechWald Holding.

Nitinote Surgical operates through Nitinotes Ltd..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available